Ironwood Pharmaceuticals competitive analysis

Explore patent oppositions filed by Ironwood Pharmaceuticals against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 10, 2026
Patent NumberTitleApplicantOpposition Date
Dosage Regimes For The Administration Of Glucagon-Like-Peptide-2 (Glp-2) AnaloguesZEALAND PHARMAApr 29, 2025

Explore Ironwood Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 10, 2026
Patent NumberPublication DateTitleTotal Oppositions
Dec 14, 2016Treatments For Gastrointestinal Disorders1

Latest PTAB cases involving Ironwood Pharmaceuticals

Discover the latest PTAB cases involving Ironwood Pharmaceuticals, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 10, 2026
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Ironwood Pharmaceuticals

IPR2018-01363Jul 6, 2018SYNERGY PHARMACEUTICALSIRONWOOD PHARMACEUTICALSTerminated-Settled

Peer Comparison New

IP litigation analysis comparing Ironwood Pharmaceuticals with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 10, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
IRONWOOD PHARMACEUTICALS11 - 1
HEXAL976 - -
SYNERGY PHARMACEUTICALS - - 1 -
ZEALAND PHARMA12 - -